Insulet Long Term Debt 2010-2024 | PODD
Insulet long term debt from 2010 to 2024. Long term debt can be defined as the sum of all long term debt fields.
- Insulet long term debt for the quarter ending December 31, 2024 was $1.296B, a 5.14% decline year-over-year.
- Insulet long term debt for 2024 was $1.296B, a 5.14% decline from 2023.
- Insulet long term debt for 2023 was $1.366B, a 0.57% decline from 2022.
- Insulet long term debt for 2022 was $1.374B, a 10.05% increase from 2021.
| Insulet Annual Long Term Debt (Millions of US $) |
|
|---|---|
| 2024 | $1,296 |
| 2023 | $1,366 |
| 2022 | $1,374 |
| 2021 | $1,249 |
| 2020 | $1,044 |
| 2019 | $888 |
| 2018 | $592 |
| 2017 | $566 |
| 2016 | $333 |
| 2015 | $172 |
| 2014 | $166 |
| 2013 | $119 |
| 2012 | $104 |
| 2011 | $109 |
| 2010 | $69 |
| 2009 | $89 |
| Insulet Quarterly Long Term Debt (Millions of US $) |
|
|---|---|
| 2024-12-31 | $1,296 |
| 2024-09-30 | $1,356 |
| 2024-06-30 | $1,360 |
| 2024-03-31 | $1,363 |
| 2023-12-31 | $1,366 |
| 2023-09-30 | $1,371 |
| 2023-06-30 | $1,369 |
| 2023-03-31 | $1,369 |
| 2022-12-31 | $1,374 |
| 2022-09-30 | $1,380 |
| 2022-06-30 | $1,385 |
| 2022-03-31 | $1,391 |
| 2021-12-31 | $1,249 |
| 2021-09-30 | $1,257 |
| 2021-06-30 | $1,235 |
| 2021-03-31 | $1,052 |
| 2020-12-31 | $1,044 |
| 2020-09-30 | $922 |
| 2020-06-30 | $910 |
| 2020-03-31 | $899 |
| 2019-12-31 | $888 |
| 2019-09-30 | $986 |
| 2019-06-30 | $607 |
| 2019-03-31 | $600 |
| 2018-12-31 | $592 |
| 2018-09-30 | $584 |
| 2018-06-30 | $577 |
| 2018-03-31 | $570 |
| 2017-12-31 | $566 |
| 2017-09-30 | $345 |
| 2017-06-30 | $341 |
| 2017-03-31 | $337 |
| 2016-12-31 | $333 |
| 2016-09-30 | $329 |
| 2016-06-30 | $176 |
| 2016-03-31 | $174 |
| 2015-12-31 | $172 |
| 2015-09-30 | $175 |
| 2015-06-30 | $175 |
| 2015-03-31 | $175 |
| 2014-12-31 | $166 |
| 2014-09-30 | $171 |
| 2014-06-30 | $175 |
| 2014-03-31 | $121 |
| 2013-12-31 | $119 |
| 2013-09-30 | $117 |
| 2013-06-30 | $112 |
| 2013-03-31 | $106 |
| 2012-12-31 | $104 |
| 2012-09-30 | $102 |
| 2012-06-30 | $99 |
| 2012-03-31 | $111 |
| 2011-12-31 | $109 |
| 2011-09-30 | $106 |
| 2011-06-30 | $104 |
| 2011-03-31 | $71 |
| 2010-12-31 | $69 |
| 2010-09-30 | $94 |
| 2010-06-30 | $92 |
| 2010-03-31 | $98 |
| 2009-12-31 | $89 |
| 2009-09-30 | $96 |
| 2009-06-30 | $83 |
| 2009-03-31 | $81 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | MED PRODUCTS | $18.084B | $2.072B |
| Insulet Corporation is a leading developer, manufacturer and marketer of the Omnipod Insulin Management System. The system is equipped with a self-adhesive, small and lightweight disposable tubeless Omnipod device along with the wireless and handheld Personal Diabetes Manager (PDM). The Omnipod System is an innovative, discreet and easy-to-use continuous insulin delivery system for people with insulin-dependent diabetes. The Omnipod System consists of Omnipod Insulin Management System ('Omnipod') and the Omnipod DASH Insulin Management System - Insulet's next generation digital mobile Omnipod platform. Insulet has tied up with pharmaceutical and biotechnological companies using customized form of the Omnipod System to deliver a drug at a certain administered volume and over a specified period of time. Insulet has partnered with pharmaceutical and biotechnology companies to tailor the Omnipod System technology platform for the delivery of subcutaneous drugs across other therapeutic areas. | |||